THOREN NATASHA FAY enters X4 PHARMACEUTICALS, INC with 6.98K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/3/2025ACC: 0001628280-25-029175
Officer· Chief Legal Officer
Since May 2025
6.98K
Baseline shares
100% direct
6.98K
Direct ownership
1 position
8.17K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned6.98K
Total
6.98K direct6.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.98K | Direct |
| Total | 6.98K | 6.98K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
8.17K
Shares owned
N/A
Exercise price
32.70
Expiration
—
Exercise window
—
Total
Underlying
8.17K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 32.70 | — | — | 8.17K | N/A |
| Total | 8.17K | 0.00 | ||||